About US
Contact us
-
Roche Reports New Method for Efficiently Transporting Antibodies Across the Blood-Brain BarrierResults published in Neuron demonstrate efficacy in preclinical mouse models of Alzheimer's disease. The scientific journal Neuron has published results on the Roche-designed Brain Shuttle technolo2014/1/17
-
FDA approves AstraZeneca and BMS' diabetes drug FARXIGAThe US Food and Drug Administration (FDA) has approved AstraZeneca and Bristol-Myers Squibb's (BMS) FARXIGA (dapagliflozin), a once-daily oral treatment for the improvement of glycaemic control in adu2014/1/16
-
Chelsea obtains FDA panel recommendation for Northera for treatment of symptomatic nOHThe Food and Drug Administration's (FDA) cardiovascular and renal drugs advisory committee (CRDAC) voted 16-1 to recommend approval for Chelsea Therapeutics' Northera (droxidopa) to treat symptomatic2014/1/16
-
Bayer and Regeneron to develop potential drug for wet age-related macular degenerationBayer HealthCare and Regeneron Pharmaceuticals have agreed to collaborate on the development of a new antibody to platelet-derived growth factor receptor beta (PDGFR-ß) as a potential combinatio2014/1/15
-
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus TherapeuticsEli Lilly and Companyhas announced that, based on positive PhaseII data, it has acquired all development rights for a calcitonin gene-related peptide (CGRP) antibody currently being studied as a poten2014/1/15
-
Alnylam buys Merck's Sirna TherapeuticsAlnylam Pharmaceuticals has acquired Merck's subsidiary Sirna Therapeutics, comprising intellectual property and RNAi assets, including pre-clinical therapeutic candidates, chemistry, siRNA-conjugate2014/1/14
-
Lonza Extends Partnership with Pharmacyclics to Support Manufacturing of Recently Approved Oncology Therapeutic, IMBRUVICALonza, a leading supplier in Chemical Development and Manufacturing, has established an agreement with Pharmacyclics, Inc. to support the commercial and clinical production of its first-in-class oral2014/1/14
-
USP Proposal on Temperature Control During Storage and DistributionThe article provides a brief overview of drug product stability studies and practices with focus on temperature control during storage and distribution. The authors state that "recent stability studie2014/1/13
-
GSK's Mekinist-Tafinlar combination gets FDA accelerated approval for melanoma treatmentGlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration (FDA) for the use of Mekinist (trametinib) in combination with Tafinlar (dabrafenib) for treatment of patients with2014/1/13
-
BioLineRx and JHL Biotech partner to develop type 1 diabetes treatmentIsrael-based clinical-stage biopharmaceutical firm BioLineRx has entered into a collaboration with Taiwanese firm JHL Biotech for the joint development and commercialisation of BL-9020, a new monoclon2014/1/10